Mar 25, 2020 - The coronavirus outbreak has made shares of top drugmakers more attractive than they've been in a quite a while.
Mar 30, 2020 - DexCom and Pfizer are both absurdly cheap right now.
Mar 30, 2020 - Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.
Apr 09, 2020 - Biotech and big pharma are putting vaccines using messenger RNA to the coronavirus test.
Apr 13, 2020 - There's just too much risk in oil and gas these days.
Apr 22, 2020 - AbbVie and Pfizer are rock-solid dividend stocks.
Apr 28, 2020 - Pfizer Inc. (NYSE:PFE) Q1 2020 Results Conference Call April 28, 2020 10:00 AM ET Company Participants Chuck Triano - SVP, IR Albert Bourla - Chairman and CEO Frank D’Amelio - CFO Mikael Dolsten - Pre
Apr 28, 2020 - PFE earnings call for the period ending March 29, 2020.
Mar 25, 2020 - Pfizer (PFE) gets FDA approval for label expansion of Eucrisa to include children aged three months to two years with mild-to-moderate atopic dermatitis or eczema.
Mar 30, 2020 - AstraZeneca's (AZN) Imfinzi gets FDA approval as first-line treatment for extensive-stage small cell lung cancer patients. A phase III study on Farxiga in CKD patients meets endpoint earlier than expected.